For years, smoke shops, gas stations, and online retailers have sold products marketed as “legal highs.” Some are framed as wellness products. Others are sold as energy boosters, mood enhancers, pain relievers, or alternatives to opioids, alcohol, or prescription medications.
One of the most concerning substances in that market is 7-OH, short for 7-hydroxymitragynine. It is a kratom-related compound that can produce opioid-like effects. While 7-OH occurs naturally in trace amounts in the kratom plant, many newer products contain concentrated, semi-synthetic, or enhanced forms of 7-OH that are far more potent than ordinary leaf kratom.
On July 1, 2026, the Drug Enforcement Administration announced its intent to temporarily place certain 7-OH products and related substances into Schedule I of the Controlled Substances Act. The DEA said one notice addresses 7-OH above a specified threshold, while a second notice addresses related substances including mitragynine pseudoindoxyl, MGM-15, and MGM-16. Once the temporary scheduling orders take effect, covered manufacture, distribution, sale, and possession would fall under the Controlled Substances Act.
This change matters because many people using 7-OH did not start with illicit opioids. Some started with kratom. Some started with a gas station tablet or shot. Some were trying to manage pain, anxiety, opioid withdrawal, depression, or work stress. Others were simply told it was legal, natural, or “not a real drug.”
At Brooks Healing Center, we believe people deserve clear information without shame. If 7-OH has become hard to stop, you are not weak. You may be dealing with a real opioid-like dependence that deserves real support.
What Is 7-OH?
7-OH, or 7-hydroxymitragynine, is a psychoactive alkaloid connected to the kratom plant, Mitragyna speciosa. In natural botanical kratom, 7-OH is usually present only in trace amounts. The Federal Register notice explains that 7-OH can also be synthesized from mitragynine through a chemical reaction, which is part of why high-potency 7-OH products have become such a concern.
The problem is not simply that 7-OH is “from kratom.” The bigger concern is that many commercial products are not comparable to plain kratom leaf. They may contain elevated levels of 7-OH, inconsistent concentrations, or synthetic derivatives that users cannot accurately dose.
At a Glance: 7-OH and the DEA Action
| Topic | What It Means |
|---|---|
| Substance | 7-hydroxymitragynine, also called 7-OH |
| Product types | Tablets, capsules, gummies, powders, shots, strips, and extracts |
| Why regulators are concerned | Opioid-like effects, dependence, withdrawal, unpredictable potency, and overdose risk |
| DEA action | Notice of intent to temporarily place certain 7-OH products above a threshold into Schedule I |
| Related substances named | Mitragynine pseudoindoxyl, MGM-15, and MGM-16 |
| Is natural kratom leaf the main target? | No. Federal agencies state the action is aimed at enhanced or high-7-OH products, not natural leaf kratom below the threshold |
| What users should know | Stopping suddenly may cause withdrawal, especially after daily or high-dose use |
Is 7-OH Being Banned?
The most accurate answer is: the DEA has begun the temporary scheduling process for certain 7-OH products and related substances.
That distinction matters. The July 2026 DEA announcement was not written as a blanket ban on all kratom. It focused on 7-OH above a specified threshold and certain related synthetic or semi-synthetic substances. HHS and FDA also stated that these actions are not intended to regulate natural leaf kratom that does not contain enhanced levels of 7-OH.
Under the temporary scheduling process, the federal government may place a substance into Schedule I for two years when it determines the substance poses an imminent hazard to public safety. HHS stated that, after at least 30 days and consideration of public comments, the Attorney General may issue a temporary scheduling order.
In plain English: the legal status is changing quickly, and products that were openly sold may soon become federally controlled if they meet the DEA’s threshold.
Why Is the Government Targeting 7-OH?
Federal agencies are focusing on 7-OH because of its opioid-like effects and the rapid growth of concentrated products. The FDA previously stated that it was targeting concentrated 7-OH products, not natural kratom leaf, and noted that there are no FDA-approved 7-OH drugs. The FDA also stated that 7-OH is not lawful in dietary supplements and cannot lawfully be added to conventional foods.
The DEA’s Federal Register notice points to several concerns, including dependence, withdrawal, respiratory depression, serious adverse events, and products with inconsistent identity, purity, and strength. It also notes poison center and adverse event data involving 7-OH, including reports of serious outcomes and deaths.
For people who use 7-OH, the most important point is not the politics of kratom regulation. It is this: if a product acts like an opioid in the body, it can also create opioid-like dependence.
State action has already been building: as of early 2026, six states listed mitragynine and 7-OH as controlled substances, while 30 states and Washington, D.C., had some form of kratom regulation, and additional states have since moved specifically against concentrated 7-OH products.
How 7-OH Dependence Can Happen
Many people do not recognize 7-OH dependence until they try to stop. That is because products may be marketed as legal, plant-based, or safer than opioids. Over time, tolerance can build. A person may need more of the product to feel normal, avoid withdrawal, sleep, work, or manage emotions.
Signs of possible 7-OH dependence may include:
- Taking 7-OH every day or multiple times per day
- Needing higher doses than before
- Feeling anxious, sweaty, restless, or sick when skipping a dose
- Waking up in withdrawal
- Using 7-OH to avoid feeling “off”
- Spending more money than intended
- Hiding use from family, coworkers, or people in recovery
- Trying to quit and repeatedly going back
- Switching between 7-OH, kratom, tianeptine, alcohol, or other substances
Withdrawal can feel similar to opioid withdrawal for some people. Symptoms may include sweating, chills, body aches, diarrhea, nausea, anxiety, insomnia, irritability, restless legs, cravings, and fatigue.
What the Ban Could Mean for Current 7-OH Users
A temporary ban or scheduling order does not automatically make dependence disappear. In fact, sudden market changes can create new risks.
People who are physically dependent may panic-buy, rapidly taper without support, switch to stronger substances, or turn to unregulated online sellers. Others may move from 7-OH to kratom extracts, tianeptine, illicit opioids, benzodiazepines, alcohol, or other “legal high” products.
That is why the safest response is not shame or fear. It is planning.
If you currently use 7-OH, consider these steps:
- Do not assume every replacement product is safer. Many legal or semi-legal products can still cause dependence or withdrawal.
- Avoid mixing 7-OH with alcohol, benzodiazepines, opioids, sleep medications, or other sedatives. Combining depressants can increase overdose risk.
- Do not wait until you are completely out if you already experience withdrawal. Talk to a medical or addiction professional before the situation becomes urgent.
- Be honest about dose and frequency. Treatment professionals can help more effectively when they know what you have been taking.
- Seek help if you are switching substances to avoid withdrawal. That pattern can quickly become dangerous.
What Will Be Left on the Market?
When one “legal high” is restricted, the market often shifts. That does not mean the remaining products are safe. It usually means consumers need to be even more cautious.
Products That May Remain Available
| Product Category | Why People Use It | Key Concern |
|---|---|---|
| Plain kratom leaf | Pain, energy, mood, opioid withdrawal self-management | Can still cause dependence and may be illegal or restricted in some states |
| Kratom extracts | Stronger effects than plain leaf | Higher potency and greater withdrawal risk |
| Kava products | Relaxation and stress relief | Sedation, liver concerns, and risky mixing with alcohol or sedatives |
| Kanna products | Mood and social effects | Limited regulation and possible interactions with psychiatric medications |
| Tianeptine products | Mood, energy, opioid-like effects | FDA warns against tianeptine products due to serious risks including dependence, overdose, and death |
| “Nootropic” blends | Focus, energy, mood | Hidden ingredients, stimulant effects, and inconsistent labeling |
| Hemp-derived intoxicants | Relaxation, sleep, intoxication | Impairment, anxiety, dependency patterns, and state-by-state legal issues |
Tianeptine is especially concerning because it is often sold in gas stations, vape shops, and online, and the FDA has warned consumers about serious risks associated with these products. The FDA describes tianeptine as a substance not approved for any medical use in the United States and has warned about severe adverse events including agitation, drowsiness, confusion, sweating, rapid heartbeat, high blood pressure, nausea, vomiting, slowed or stopped breathing, coma, and death.
The lesson is simple: legal availability does not equal safety.
Why “Legal High” Products Can Be So Hard to Quit
Many people feel blindsided by products like 7-OH because they do not fit the stereotype of addiction. They may be sold next to energy drinks, nicotine products, or supplements. The packaging may look clean, modern, or wellness-oriented. The person using them may have never bought illicit drugs.
That can create a painful kind of confusion:
- “How did I get dependent on something legal?”
- “Why do I feel withdrawal from a smoke shop product?”
- “Will people think I relapsed?”
- “Can I still be in recovery if this happened?”
- “Do I need detox?”
These are real questions. They deserve honest answers.
Dependence can happen when a substance changes the brain and body over time. Whether the product came from a pharmacy, a gas station, a smoke shop, or a website, the body can still adapt to it. When the substance is removed, withdrawal can follow.
When to Consider Detox or Treatment for 7-OH
Not everyone who uses 7-OH needs inpatient treatment. However, professional help may be important if you:
- Cannot stop despite wanting to
- Experience withdrawal when you miss a dose
- Use 7-OH throughout the day
- Combine 7-OH with alcohol, opioids, benzodiazepines, or other substances
- Have a history of opioid use disorder
- Are in recovery and feel afraid to tell anyone
- Have severe anxiety, depression, or suicidal thoughts
- Are using more than intended
- Are switching to other substances because 7-OH is becoming harder to find
- Have tried tapering but cannot stabilize
Medical detox can help manage withdrawal symptoms and reduce the risk of returning to more dangerous substances. Residential treatment or outpatient care may also help address the emotional, behavioral, and relapse-related parts of dependence.
Is 7-OH Withdrawal the Same as Opioid Withdrawal?
For some people, it can feel very similar. 7-OH interacts with opioid receptors, which is why users may report pain relief, euphoria, relaxation, or a sense of warmth. It is also why withdrawal can include opioid-like symptoms.
Possible 7-OH withdrawal symptoms include:
- Sweating
- Chills
- Body aches
- Restlessness
- Anxiety
- Depression
- Insomnia
- Nausea
- Diarrhea
- Runny nose
- Watery eyes
- Fatigue
- Strong cravings
- Irritability
- Restless legs
Withdrawal severity can depend on the dose, product potency, frequency of use, length of use, other substances involved, and a person’s medical history.
Medication-Assisted Treatment for Opioids, Kratom, and 7-OH Variants
Medication-assisted treatment, often called MAT, can be an important option for people struggling with opioids, kratom extracts, 7-OH, or other opioid-like products. MAT combines FDA-approved medications, like Sublocade or Suboxone, with clinical support, counseling, and recovery planning. The goal is not to “replace one addiction with another.” The goal is to help stabilize the brain and body so a person can stop chasing withdrawal relief and start rebuilding their life.
For people using 7-OH or high-potency kratom products, one of the biggest dangers is uncertainty. Packaging may not clearly show what is inside. Potency can vary from product to product. Some products may contain concentrated 7-OH, synthetic or semi-synthetic variants, or other active ingredients that users did not knowingly choose. That makes self-tapering difficult and can increase the risk of taking too much, mixing substances, or switching to illicit opioids when the original product becomes unavailable.
MAT offers a safer, supervised alternative. Instead of relying on smoke shop products, gas station tablets, online extracts, or unregulated powders, a person can work with medical professionals who understand withdrawal, cravings, relapse risk, and dose stabilization. When appropriate, medications such as buprenorphine-based treatment or naltrexone may help reduce cravings, ease withdrawal symptoms, and lower the risk of returning to illicit opioids or other unpredictable substances.
This can be especially helpful when a market changes quickly. If 7-OH products become harder to find, more expensive, or illegal to purchase, people who are physically dependent may feel pressured to make risky decisions. Some may try stronger kratom extracts. Others may turn to tianeptine, counterfeit pills, fentanyl, heroin, or other substances to avoid withdrawal. MAT can help interrupt that cycle by giving people a medically supervised path forward before desperation takes over.
MAT may help people who:
- Have a history of opioid use disorder
- Are dependent on kratom extracts or 7-OH products
- Experience withdrawal when they stop or reduce use
- Have tried tapering but cannot stabilize
- Are afraid they may return to illicit opioids
- Use opioid-like products throughout the day to feel normal
- Feel trapped by cravings, shame, or fear of withdrawal
For many people, MAT provides the stability needed to participate in therapy, rebuild trust with family, return to work, and create a long-term recovery plan. It can also reduce the fear that comes from not knowing what is in a product or how strong the next dose may be.
At Brooks Healing Center, MAT is not treated as a shortcut or a one-size-fits-all solution. It is a clinical tool that may be used when it supports safety, recovery, and long-term progress. Some people may need detox first. Others may benefit from ongoing medication management, therapy, and relapse prevention support. The right plan depends on the person, the substances involved, their medical history, and their recovery goals.
If you are using opioids, kratom extracts, 7-OH tablets, or other opioid-like products and feel afraid of what will happen when you stop, MAT may be worth discussing. You do not have to manage withdrawal alone, guess what is in a package, or wait until illicit drugs feel like the only option. Supervised treatment can help you move from uncertainty and survival mode into a safer, more stable path toward recovery.
What This Means for People in Recovery
The rise of 7-OH has created a difficult situation for many people in recovery. Some were told it was safe because it was legal. Some used it to manage pain or anxiety. Some used it instead of returning to opioids. Some did not realize they were taking a product with opioid-like effects until withdrawal started.
If this happened to you, it does not mean you are hopeless. It means you need support and honesty, not isolation.
Recovery communities can sometimes struggle to talk about gray-area substances. But silence can make things worse. If someone is dependent on 7-OH, they may need the same compassion and clinical support as anyone dealing with opioid-like withdrawal.
How Brooks Healing Center Can Help
Brooks Healing Center provides addiction treatment in Tennessee for people struggling with substance use, relapse risk, and dependence on emerging substances like 7-OH, kratom extracts, tianeptine, and other legal high products.
Our team understands that not every addiction story begins the same way. Some people come to treatment after years of opioid use. Others come after becoming dependent on something they bought legally. Either way, the goal is the same: safety, stabilization, honesty, and long-term recovery.
Depending on your needs, treatment may include:
- Clinical assessment
- Detox coordination when appropriate
- Residential addiction treatment
- Individual therapy
- Group therapy
- Relapse prevention planning
- Support for co-occurring anxiety, depression, trauma, or grief
- Recovery planning for life after treatment
You do not have to wait until things get worse. If 7-OH has become part of your daily routine, or if you are worried about withdrawal as the market changes, help is available.
Final Thoughts
The DEA’s temporary scheduling move marks a major turning point for 7-OH products. While the action is aimed at concentrated or enhanced 7-OH products rather than natural kratom leaf below the threshold, it signals that federal agencies view 7-OH as a serious public health concern.
For users, the biggest question is not just “Will this still be legal?” It is “What happens to me if I cannot stop?”
If you are using 7-OH and feel stuck, you are not alone. Legal status does not define whether a substance is addictive. Packaging does not define whether withdrawal is real. And shame should never be the reason someone avoids getting help.
Brooks Healing Center is here to help you take the next step toward stability, clarity, and recovery.
Frequently Asked Questions About The DEA Temporary Scheduling of 7-OH Products
Is kratom federally legal?
Kratom itself is not currently listed as a federally controlled substance under the Controlled Substances Act. However, that does not mean all kratom products are legally marketed or considered safe. The FDA states that kratom is not lawfully marketed in the U.S. as a drug product, dietary supplement, or food additive, and it continues to warn consumers about risks such as liver toxicity, seizures, substance use disorder, and withdrawal. State laws may also ban or restrict kratom, so legality can vary depending on where a person lives.
Is 7-OH federally legal?
The federal status of 7-OH is changing. On July 1, 2026, the DEA filed its intent to temporarily place 7-hydroxymitragynine, or 7-OH, above a specified threshold into Schedule I of the Controlled Substances Act. Once the temporary scheduling order takes effect, covered 7-OH products would become subject to federal criminal, civil, and administrative controls. Separately, the FDA has stated that 7-OH is not lawful in dietary supplements, cannot lawfully be added to conventional foods, and is not approved in any FDA-approved drug.
Is MGM-15 federally legal?
MGM-15 is specifically named in the DEA’s July 2026 temporary scheduling action. The DEA notice addresses moving three 7-OH-related substances—mitragynine pseudoindoxyl, MGM-15, and MGM-16—into Schedule I of the Controlled Substances Act. HHS describes MGM-15 as a synthetic derivative of 7-OH that does not occur naturally in the kratom plant. Once the temporary scheduling order takes effect, covered manufacture, distribution, sale, and possession would be regulated under the Controlled Substances Act.
Is pseudoindoxyl federally legal?
Mitragynine pseudoindoxyl, sometimes shortened to pseudoindoxyl or MP, is also named in the DEA’s July 2026 temporary scheduling action. HHS states that mitragynine pseudoindoxyl is a chemical rearrangement product of 7-OH, not natural leaf kratom. The DEA’s second Notice of Intent addresses placing mitragynine pseudoindoxyl, MGM-15, and MGM-16 into Schedule I of the Controlled Substances Act. Once that order takes effect, covered pseudoindoxyl products would be federally controlled.
Does SR-17 work for 7-OH or kratom detox?
There is no FDA-approved SR-17 medication for 7-OH detox, kratom detox, or opioid withdrawal treatment. Some people may use “SR-17” to refer to experimental opioid-receptor research compounds such as SR-17018, but these are not approved detox medications and should not be used as a self-directed treatment. Available research on compounds like SR-17018 is preclinical and experimental, not evidence that it is safe or effective for human 7-OH or kratom withdrawal. People struggling with kratom, 7-OH, or opioid-like withdrawal should speak with a qualified medical provider about supervised detox, symptom management, and evidence-based treatment options such as medication-assisted treatment when appropriate.
Why can state laws prohibit certain drugs when they are federally legal and vice versa?
State and federal governments can regulate drugs separately. A substance may be federally legal but still banned, restricted, or age-limited by a state. A substance may also be allowed under state law while still being illegal federally. This happens because federal law sets national rules, while states can create their own public health and safety laws within their borders. For example, a state may choose to ban or regulate kratom, 7-OH, hemp-derived intoxicants, or other substances even if federal law has not fully scheduled them. On the other hand, cannabis is legal for medical or adult use in many states but remains federally illegal under the Controlled Substances Act. Because of this overlap, consumers and businesses must look at both federal law and the law in their specific state before assuming a product is legal to possess, sell, or use.
Sources
Drug Enforcement Administration. (2026, July 1). DEA to temporarily schedule 7-OH and related substances to protect public safety. https://www.dea.gov/press-releases/2026/07/01/dea-temporarily-schedule-7-oh-and-related-substances-protect-public
Federal Register. (2026, July 6). Schedules of controlled substance: Temporary placement of 7-hydroxymitragynine above a specified threshold in Schedule I. https://www.federalregister.gov/documents/2026/07/06/2026-13580/schedules-of-controlled-substance-temporary-placement-of-7-hydroxymitragynine-above-a-specified
U.S. Department of Health and Human Services. (2026, July 1). HHS, FDA commend DEA action against dangerous enhanced 7-OH products. https://www.hhs.gov/press-room/hhs-fda-support-dea-7-oh-scheduling.html
U.S. Food and Drug Administration. (2025, July 29). FDA takes steps to restrict 7-OH opioid products threatening American consumers. https://www.fda.gov/news-events/press-announcements/fda-takes-steps-restrict-7-oh-opioid-products-threatening-american-consumers
U.S. Food and Drug Administration. (2025, May 8). New “gas station heroin” tianeptine product trend. https://www.fda.gov/consumers/health-fraud-scams/new-gas-station-heroin-tianeptine-product-trend
Associated Press. (2025, July 29). US health officials crack down on kratom-related products after complaints from supplement industry. AP News. https://apnews.com/article/kennedy-hhs-kratom-978e5beb6e3067f6bcf1ee45ec16372a
Pierson, B. (2026, July 1). DEA moves to place some strong kratom-related products under strict federal drug controls. Reuters. https://www.reuters.com/legal/litigation/dea-moves-place-some-strong-kratom-related-products-under-strict-federal-drug-2026-07-01/
